Rebalix
Logo Franklin TempletonFranklin Templeton · sheet of 10 September 2026
ETF sheet · official issuer and register data

Franklin Future of Health and Wellness UCITS ETF

FOHW · IE0003WEWAX4 · class SINGLCLASS · USD · domicile Ireland
Equity · Sustainable / ESGSFDR art. 8
Index tracked: Solactive Sustainable Health and Wellness Index-NR
TER
0.30%+ trans. 0.14%
Fund size
3 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 5 Jul 2023 · costs from the KID as of 2 Sept 2026 · 92 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 2 Sept 2026
Investment Objective To provide exposure to companies that are involved in delivering sustainable products and services related to health and wellness globally. Investment Policy The Fund invests in equities of developed market companies that utilize technology and demonstrate innovation within the healthcare industry as well as companies that are enabling access to care, health, or wellness provision for a wide range of consumers including the elderly. To be included in the Index, such securities have, or are expected to have, exposure to the…

Performance since series start (in euro) — base 100

31 Jul 202331 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20242025202611590111
High 115 (31 Jan 2025) · low 90 (31 Oct 2023) · last 111. Past performance is not indicative of future results.

Returns in euro

1 year+11.5%
3 years+11.3%
5 yearsseries too young
10 yearsseries too young
Since series start+11.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)14.48%13.72%
Max drawdown−10.91%−16.89%
Sharpe0.500.32
Sortino0.780.46
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · FOHW · IE0003WEWAX41
RebalixFOHW · IE0003WEWAX4 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+11.67%+11.82%−0.15%
2024+2.01%+2.18%−0.17%

Holdings

Portfolio as declared by the issuer · 26 Aug 2026 · 92 securities · top-10 weight = 34.0%
Top holdingsWeight
ELI LILLY & CO USD NPV4.0%
JOHNSON & JOHNSON USD 13.9%
MERCK & CO. INC USD 0.53.6%
ABBOTT LABORATORI USD NPV3.4%
ABBVIE INC USD 0.013.4%
VERTEX PHARMACEU USD 0.013.4%
PFIZER INC USD 0.053.3%
GILEAD SCIENCES USD 0.0013.3%
NOVO NORDISK A/S DKK 0.13.1%
MEDTRONIC PLC USD 0.12.9%
Countries (% of fund)
Stati Uniti67.7%Svizzera5.9%Danimarca5.0%Francia4.5%Germania4.1%
Sectors (% of fund)
Attrezzatura sanitaria28.2%Prodotti farmaceutici25.1%Biotecnologia16.8%Strutture sanitarie6.6%Serv. & Attrez. per Scienz…4.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
FOHW · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Paris, Tradegate Exchange, Xetra (Deutsche Börse)
+ 11 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.franklintempleton.ie/download/en-ie/key-information-document/d98b2
Factsheet · www.franklintempleton.ie/download/en-ie/factsheet/6249cf33-b831-4f30-9
Prospectus · www.franklintempleton.ie/download/en-ie/prospectus/77b538e3-0d06-42a0-
The live sheet, always up to date
rebalix.com/en/etf/IE0003WEWAX4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · FOHW · IE0003WEWAX42